Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma-Reference-Cited by-同舟云学术

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

Published:2014-09-19 Issue:2 Volume:17 Page:266-273
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Penas-Prado Marta,Hess Kenneth R.,Fisch Michael J.,Lagrone Lore W.,Groves Morris D.,Levin Victor A.,De Groot John F.,Puduvalli Vinay K.,Colman Howard,Volas-Redd Gena,Giglio Pierre,Conrad Charles A.,Salacz Michael E.,Floyd Justin D.,Loghin Monica E.,Hsu Sigmund H.,Gonzalez Javier,Chang Eric L.,Woo Shiao Y.,Mahajan Anita,Aldape Kenneth D.,Yung W. K. Alfred,Gilbert Mark R.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/17/2/266/16859549/nou155.pdf

Reference33 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme;Chang;Neurosurg Focus,2006

3. Bevacizumab for the treatment of glioblastoma;Chowdhary;Expert Rev Neurother,2013

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

5. Glioblastoma: from molecular pathology to targeted treatment;Cloughesy;Ann Rev Pathol,2014

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients;Cancers;2024-06-28

2. Cytotoxic effects of nerve growth factor and its combinations with chemotherapeutic drugs on anaplastoc astrocytoma, glioblastoma and medubloblastoma cells <i>in vitro</i>;Medical academic journal;2024-05-23

3. Drug repurposing for cancer therapy;Signal Transduction and Targeted Therapy;2024-04-19

4. Emerging Therapies for Glioblastoma;Cancers;2024-04-12

5. Activity-dependent COX-2 proteolysis generates a catalytically inactive fragment that affects aerobic respiration and proliferation;2024-04-11